Roivant Sciences Ltd.
ROIV- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001635088
In the last 90 days, Roivant Sciences Ltd. insiders filed 0 open-market purchases and 7 sales; 500 institutions reported holding it in 13F filings for Q2 2026, worth $19.7B in total; 3 superinvestors hold it, including Viking Global Investors and Maverick Capital.
Q4 2021 vs. Q3 2021
How the institutions holding Roivant Sciences Ltd. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 0 | 42 | +42 |
| Shares | 0 | 339.2M | +339.2M |
| Value | $0 | $3.42B | +$3.42B |
New holders (42)
Institutions that held Roivant Sciences Ltd. at the end of Q4 2021 but not at the end of Q3 2021.
Sold out (0)
Institutions that held Roivant Sciences Ltd. at the end of Q3 2021 and filed for Q4 2021 without it.
None.